Pricing Log in Create free account
Friday 6 November 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

CORT Healthcare Biotechnology

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024.

Revenue
+64.0%
EPS
+525.8%
Free cash flow
+161.0%

Quarter to September 2026, against a year earlier

72.87 1.24 +1.73%
Market cap
$7.8B
P/E
47.5×
Fwd P/E
39.8×
Dividend yield
—
F-score
4/9
Altman Z
14.11
Beneish M
−2.76
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Corcept Therapeutics Incorporated (CORT) Current ratio

Alert me on Current ratio

Corcept Therapeutics Incorporated's current ratio at the end of the quarter to 30 September 2026 was 3.0×, up 0.1× from fiscal 2025 (2.9×). Over the past ten years it has ranged from 2.3× (fiscal 2015) to 10.1× (fiscal 2020); the current reading is higher than 27% of that period. That is below the Biotechnology industry median of 4.9× and in line with the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 2.9× (12.75%)
FY2024 3.4× (23.67%)
FY2023 4.4× (36.28%)
FY2022 6.9× 22.88%
FY2021 5.6× (44.37%)
FY2020 10.1× 27.32%
FY2019 7.9× 18.87%
FY2018 6.7× 58.51%
FY2017 4.2× 75.01%
FY2016 2.4× 2.28%

Quarterly newest first

Period Current ratio Change
Sep 2026 3.0× 5.11%
Jun 2026 2.9× 0.11%
Mar 2026 2.9× (2.30%)
Dec 2025 2.9× (6.95%)
43 more quarters

Against its own ten years

Low 2.3× High 10.1×
Ten-year median 4.4×
Current reading's percentile 27

Current ratio against peers

Company Current ratio
SYRE Spyre Therapeutics, Inc. compare 27.4×
PTGX Protagonist Therapeutics, Inc. compare 21.7×
PRAX Praxis Precision Medicines, Inc. compare 15.7×
KRYS Krystal Biotech, Inc. compare 7.9×
ABVX Abivax SA Sponsored ADR compare 6.0×
ARWR Arrowhead Pharmaceuticals, Inc. compare 5.9×
CYTK Cytokinetics, Incorporated compare 3.4×
MDGL Madrigal Pharmaceuticals, Inc. compare 3.1×
CORT Corcept Therapeutics Incorporated 3.0×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on CORT